Laserfiche WebLink
Page 3 <br />Contract Addendum <br /> <br /> PROTOCOLS: The local contractor will follow the medical <br />protocols provided by the State. Pap Smear Screeninq: A Guide for <br />Health Departments will be used for cervical cancer screening and <br />follow-up guidelines will be developed by the Program by <br />December 15, 1992. <br /> <br /> PUBLIC AND PROFESSIONAL EDUCATION: The local contractor will <br />participate in educational opportunities provided by the North <br />Carolina Comprehensive Breast and Cervical Cancer Control Program <br />and other continuing education as appropriate. <br /> <br /> SURVEILLANCE: Minimum data elements (MDE's) are required by <br />the Centers for Disease Control in order to amass the statistics to <br />provide to the Congress for the research component of this program. <br />The contractor will submit the MDE's to the state on a quarterly <br />basis according to the schedule provided. <br /> <br /> FUNDING: There is a 3:1 Federal: non-Federal matching <br />requirement; therefore, the local contractor will provide the non- <br />Federal match on the funding received from the State under this <br />contract. If a sliding fee scale is used, it will be the same as <br />the Family Planning fee scale. No woman at or below 100% of the <br />federal poverty level may be charged for services provided by this <br />program. The sliding fee scale must be posted in order for the <br />clients being served to view it. The BCCCP is the payor or last <br />resort after Medicare, Medicaid, Title X, and private insurance. <br /> <br /> REFERRAL: The contractor will assure that a referral system <br />for the diagnosis and treatment of all abnormal findings is <br />developed and a written protocol is available. The contractor will <br />designate a person who will be responsible for implementing a <br />follow-up protocol which ensures, to the best of their ability, <br />that no patient who receives program reimbursement services or <br />requires follow-up or medical treatment is lost to follow-up. For <br />all abnormal results the following information will be documented: <br /> <br />1) <br /> <br />2) <br /> <br />3) <br /> <br />follow-up appointment information (date and follow-up <br />location) <br />patient contact information (number and date of attempts <br />made to follow-up) <br />referral information (date and referral source). <br /> <br />This contract addendum will cover the period from December 1, 1992 <br />to June 3F~993. <br /> <br />Lb~l Health Director ' Date <br /> <br />Health Department <br /> <br /> <br />